Current jobs related to Director, DMPK - Cambridge - FogPharma
-
Associate Director
2 months ago
Cambridge, United States Delphia Therapeutics Full timeAbout Us:Delphia is a biotechnology company on a mission in the service of patients to pioneer an entirely new field of cancer biology, Activation Lethality, that targets cancer’s vulnerability to oncogene overactivation. Together, we are working to advance first-in-class targeted cancer medicines that can provide better and more durable outcomes for...
-
Associate Director
2 months ago
Cambridge, United States Delphia Therapeutics Full timeAbout Us:Delphia is a biotechnology company on a mission in the service of patients to pioneer an entirely new field of cancer biology, Activation Lethality, that targets cancer’s vulnerability to oncogene overactivation. Together, we are working to advance first-in-class targeted cancer medicines that can provide better and more durable outcomes for...
-
Associate Director
3 weeks ago
cambridge, United States Delphia Therapeutics Full timeAbout Us:Delphia is a biotechnology company on a mission in the service of patients to pioneer an entirely new field of cancer biology, Activation Lethality, that targets cancer’s vulnerability to oncogene overactivation. Together, we are working to advance first-in-class targeted cancer medicines that can provide better and more durable outcomes for...
-
Associate Director
3 weeks ago
cambridge, United States Delphia Therapeutics Full timeAbout Us:Delphia is a biotechnology company on a mission in the service of patients to pioneer an entirely new field of cancer biology, Activation Lethality, that targets cancer’s vulnerability to oncogene overactivation. Together, we are working to advance first-in-class targeted cancer medicines that can provide better and more durable outcomes for...
-
Senior Director, DMPK
4 months ago
Cambridge, United States Bicycle Therapeutics Full timeJob DescriptionJob DescriptionCompany DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two...
-
Associate Director, DMPK
7 days ago
cambridge, United States Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This...
-
Associate Director, DMPK
3 days ago
Cambridge, United States Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This...
-
Associate Director, DMPK
1 week ago
Cambridge, United States Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This...
-
Associate Director, DMPK
1 week ago
Cambridge, United States Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This...
-
Associate Director, DMPK
2 days ago
Cambridge, United States Bicycle Therapeutics Full timeBicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This...
-
Scientific Director, DMPK
4 weeks ago
Cambridge, United States Moderna, Inc. Full timeThe RoleAt Moderna, our mission is to deliver the greatest possible impact to people through mRNA medicines. We foster a dynamic, diverse, and innovative workplace where every individuals contribution is vital.In this role, you will serve as a Drug Metabolism and Pharmacokinetic (DMPK) subject matter expert and functional line representative on drug...
-
Cambridge, Massachusetts, United States Bicycle Therapeutics Full timeJob Title: Associate Director of Drug Metabolism and PharmacokineticsBicycle Therapeutics is a clinical-stage pharmaceutical company developing innovative medicines for underserved diseases. We are seeking an experienced Associate Director of Drug Metabolism and Pharmacokinetics (DMPK) to join our team.Key Responsibilities:Design and execute non-clinical...
-
Cambridge, Massachusetts, United States Bicycle Therapeutics Full timeJob DescriptionThe Associate Director of Drug Metabolism and Pharmacokinetics (DMPK) plays a pivotal role in the success of our drug development pipeline at Bicycle Therapeutics. Reporting to the Vice President of Quantitative Pharmacology, this individual will be responsible for representing DMPK, designing and executing non-clinical studies in support of...
-
Cambridge, Massachusetts, United States Bicycle Therapeutics Full timeJob Summary:The Senior Director of Drug Metabolism and Pharmacokinetics (DMPK) will lead a team of scientists in supporting multiple projects from target identification through to candidate selection and regulatory submission.Key Responsibilities:Provide scientific leadership across all stages of the portfolio, collaborating with drug discovery teams,...
-
Cambridge, Massachusetts, United States Recludix Pharma Full timeJob Summary:We are seeking an experienced leader to build our capabilities in support of our small molecule portfolio in inflammation and oncology through IND and development. The candidate will have strategic and scientific oversight of our small molecule discovery and development portfolio and will manage the in vitro and in vivo PK, ADME and bioanalytical...
-
Director, Pharmacometrics
4 months ago
Cambridge, United States Bicycle Therapeutics Full timeJob DescriptionJob DescriptionCompany DescriptionBicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two...
-
Lead Scientist, Molecular Bioanalytics
3 weeks ago
Cambridge, Massachusetts, United States Editas Medicine Full timeJob OverviewAt Editas Medicine, our mission is to deliver groundbreaking therapies to individuals facing serious health challenges. We are committed to scientific excellence, leveraging the transformative capabilities of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing technologies.We prioritize our workforce, fostering an environment where every team...
-
Senior Scientist, Molecular Bioanalytics
4 weeks ago
Cambridge, United States Editas Medicine Full timeJob DescriptionJob DescriptionAt Editas, we’re driven by a collective purpose, to bring transformative and life changing therapies to people living with serious diseases with the greatest unmet needs. This fuels our drive to excel in scientific innovation, allowing us to harness the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing....
-
Lead Scientist, Molecular Bioanalytics
3 weeks ago
Cambridge, Massachusetts, United States Editas Medicine Full timeAbout Editas Medicine:At Editas, we are united by a shared mission to deliver transformative therapies to individuals facing serious health challenges. This commitment drives our pursuit of scientific excellence, enabling us to leverage the potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing technologies. We recognize that our employees are the...
-
Director, Preclinical Drug Safety
4 weeks ago
Cambridge, United States Blueprint Medicines Full timeHow will your role help us transform hope into reality? Reporting to the Vice President of Preclinical Drug Safety, you will be responsible for developing and implementing toxicology strategies for multi-disciplinary program teams. You will play a critical role helping derisk and advance the research pipeline by leveraging your toxicology expertise,...
Director, DMPK
4 months ago
FogPharma is pioneering the discovery, development, and commercialization of Helicon TM
peptides, an exciting new drug modality that uniquely combines the cell-permeability of traditional small molecule drugs with the specificity, broad target accessibility and discovery speed of monoclonal antibody drugs. Our patented Helicon peptide technology allows us to modulate the activity of well-known intracellular disease drivers that have thus far evaded small molecule and biologic therapies.
FogPharma’s lead program targets β-Catenin, a cancer driver in the WNT pathway. Inhibition of β-Catenin has the potential to benefit more than one-fifth of all cancer patients and is just one of many opportunities for Fog’s lead-discovery platform to change future medicines, therapies and lives. We recently selected a lead development candidate and plan to initiate clinical development early next year.
What’s the opportunity?
FogPharma has an exciting new opportunity for a Director, DMPK/Clinical Pharmacology reporting to our AVP, Clinical Pharmacology/Development DMPK. In this role, you will be responsible for the design and implementation of clinical pharmacology aspects of patient trials. You will be responsible for programs from IND submission through clinical proof-of-concept. You will collaborate with your colleagues in Discovery DMPK, biology, preclinical safety, clinical development, clinical operations, translational medicine and biostatistics to deliver high-quality deliverables following selection of a development candidate through clinical proof-of-concept.
Responsibilities
Be an expert in clinical pharmacology with demonstrated experience in using and advocating the use of quantitative analyses to support drug development.
Collaborate with clinical study teams to optimize patient trial design, execute clinical studies and contribute to relevant sections of clinical study protocols.
Explore exposure-response relationships for safety and efficacy using preclinical, translational and clinical data to support dose/dosing regimen selection for clinical evaluation.
Ensure high-quality and timely delivery of relevant sections of regulatory documents for global health authority submissions.
Represent clinical pharmacology as subject matter expert on cross-functional project teams and global health authority interactions.
Provide oversight for DMPK/clinical pharmacology related sample management activities including management of BA CROs.
Contribute to the design and oversight of toxicokinetic aspects for GLP toxicology studies.
Establish and maintain productive relationships with key internal business partners, consultants, and CROs.
Additional duties and responsibilities as required.
What you’ll need to be successful:
PhD or PharmD in clinical pharmacology, pharmacometrics, or related discipline with at least 7 years of experience in the pharmaceutical and/or biotech industry
Hands-on experience in population pharmacokinetics/pharmacodynamics, and other modeling and simulation approaches to investigate PK/PD relationships for peptides therapeutics.
In-depth knowledge of bioanalytical methods to assess PK and disposition of peptide therapeutics in biological matrices.
Excellent critical thinking and scientific skills with a demonstrated ability to analyze, interpret, and clearly communicate complex results.
Ability to work effectively and collaboratively on cross-functional project teams.
Experience with parenteral drug development in oncology preferred.
Experience with health authority interactions and regulatory filings preferred.
Experience as a contributing clinical pharmacologist on a successful NDA/BLA submission preferred.
Familiar with GLP, GCP, and ICH requirements.
As an equal opportunity employer, Fog values diversity and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.
For government reporting purposes, we ask candidates to respond to the below self-identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.
As set forth in FogPharma’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.
If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:
A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.
A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.
An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.
An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.
Voluntary Self-Identification of Disability
Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026
Voluntary Self-Identification
For government reporting purposes, we ask candidates to respond to the below self-identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.
As set forth in FogPharma’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.
Gender
Are you Hispanic/Latino?
Race & Ethnicity Definitions
If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:
A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.
A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.
An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.
An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.
Veteran Status
Voluntary Self-Identification of Disability
Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026
Why are you being asked to complete this form?
We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.
Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp .
How do you know if you have a disability?
A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability.
Disabilities include, but are not limited to:
Alcohol or other substance use disorder (not currently using drugs illegally)
Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
Blind or low vision
Cancer (past or present)
Cardiovascular or heart disease
Celiac disease
Cerebral palsy
Deaf or serious difficulty hearing
Diabetes
Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
Epilepsy or other seizure disorder
Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
Intellectual or developmental disability
Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
Missing limbs or partially missing limbs
Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
Partial or complete paralysis (any cause)
Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
Short stature (dwarfism)
Traumatic brain injury
Disability Status
PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.
#J-18808-Ljbffr
